Pharma IP & Research Security Intelligence

Pharma IP & Research Security Intelligence Challenge:

Pharmaceutical organizations manage highly valuable research assets including drug discovery data, clinical trial information, laboratory systems, intellectual property, scientific documentation, and collaboration platforms. These environments generate large volumes of security telemetry and access activity, but traditional monitoring tools often struggle to correlate research, identity, and operational signals to detect sophisticated threats targeting intellectual property.

This leads to:

• Limited visibility across research and clinical environments
• Delayed detection of data exfiltration and IP theft attempts
• Difficulty identifying unauthorized access to clinical trial information
• Increased investigation effort and response delays
• Limited visibility into insider threats and collaboration risks
• Manual compliance reporting and audit preparation
• Incomplete evidence lineage across research systems

As pharmaceutical research becomes increasingly collaborative and data-driven, organizations require contextual intelligence capable of connecting security events, research activity, and regulatory requirements into a unified security view.

Our Solution: Pharma IP & Research Security Intelligence Platform (ElixirData)

ElixirData (Context OS) provides a contextual security intelligence layer that builds a unified security graph across pharmaceutical research environments.

The platform continuously ingests laboratory access events, identity activity, collaboration platform logs, clinical research data, security telemetry, and operational events to identify and correlate security threats in real time.

It integrates with:

• Clinical research platforms
• Laboratory information systems (LIMS)
• Electronic Lab Notebooks (ELN)
• Identity and access management platforms
• Collaboration and document management systems
• Security monitoring and SIEM platforms

The platform:

• Correlates access activity across research and operational systems
• Detects data exfiltration attempts and unauthorized access
• Identifies insider threat indicators and anomalous user behavior
• Tracks relationships across researchers, systems, datasets, and applications
• Maintains contextual evidence lineage across research environments
• Generates investigation evidence and compliance intelligence
• Maps security findings to FDA 21 CFR Part 11 requirements

This enables:

• Unified visibility across research security environments
• Faster detection of IP theft and data exfiltration risks
• Real-time correlation of identity, research, and security events
• Improved investigations and compliance readiness
• Continuous security intelligence and operational awareness

Unlike traditional security monitoring tools, ElixirData transforms fragmented research security signals into contextual, decision-ready intelligence.

AWS-Native Deployment Architecture:

The platform leverages:

• Amazon EKS
• Amazon MSK
• AWS Lambda
• Amazon CloudWatch
• Amazon S3
• Amazon OpenSearch Service

This enables secure and scalable research security intelligence across pharmaceutical environments.

Key Benefits:

• Protects pharmaceutical intellectual property and research assets
• Detects unauthorized access and data exfiltration faster
• Correlates identity, research, and security events in real time
• Accelerates investigations and forensic analysis
• Improves FDA 21 CFR Part 11 compliance readiness
• Reduces manual investigation and reporting effort
• Enhances research security governance
• Provides complete evidence lineage and audit traceability

Professional Services Scope:

We provide end-to-end services including:

• Assessment & Discovery

  • Analysis of research security operations and IP protection workflows
  • Evaluation of LIMS, ELN, clinical platforms, identity systems, and security environments
  • Identification of visibility, compliance, and governance gaps

• Implementation & Integration

  • Deployment of ElixirData on AWS
  • Integration with research platforms, identity services, collaboration tools, and SIEM solutions
  • Configuration of contextual security graphs, investigation workflows, and evidence lineage
  • Setup of FDA 21 CFR Part 11 compliance reporting frameworks

• Managed Services

  • Continuous monitoring and optimization
  • Security intelligence tuning and investigation refinement
  • Performance monitoring and operational improvements
  • Cost optimization and scalability management

Ideal Customers:

• Pharmaceutical Manufacturers
• Biotechnology Companies
• Clinical Research Organizations (CROs)
• Drug Discovery Organizations
• Life Sciences Research Institutes

Buyer Personas:

• Chief Information Security Officer (CISO)
• VP Research IT Security
• Research Security Teams
• Clinical IT & Compliance Leaders
• Pharmaceutical Risk & Governance Teams